nifedipine has been researched along with Kidney Diseases in 60 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nilvadipine appears to be an effective hypotensive agent at single daily doses of 8 mg." | 5.28 | Nilvadipine in hypertension with renal dysfunction. ( Albert, FW; Berger, HH, 1992) |
| "In patients with chronic renal failure and hypertension due to primary renal disease, fosinopril significantly differed from nifedipine GITS by its capacity to slow the progressive decay in renal function." | 5.09 | A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease. ( Aljama, P; Aranda, P; Diez, J; Marin, R; Ruilope, LM; Segura, J, 2001) |
| "A double-blind randomized, clinical trial was conducted in 43 patients to evaluate the efficacy of sublingual nifedipine in the treatment of pain in renal colic." | 5.06 | Nifedipine in the treatment of renal colic. ( Lloret, J; Monmany, J; More, J; Muñoz, J; Puig, X; Vila, A, 1986) |
| "Two hundred eighty-six outpatients prescribed three different CCBs (benidipine [CAS 91599-74-5], amlodipine [CAS 111470-99-6] and controlled release nifedipine (nifedipine CR) [CAS 21829-25-4]) for hypertension in combination with ARBs during a 4-year period were registered in a retrospective comparative study." | 3.76 | Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study. ( Futenma, A; Imai, H; Kimura, Y; Maeda, K; Miura, N; Suga, N; Yamada, H, 2010) |
| "Long-acting nifedipine tablets were given to 47 severely and moderately hypertensive patients with renal insufficiency, cardiovascular, cerebrovascular, and peripheral vascular disease, diabetes mellitus, asthma, and systemic lupus erythematosus." | 3.67 | Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases. ( Bursztyn, M; Grossman, E; Rosenthal, T, 1985) |
| "25 hypertensive patients with normal or impaired renal function underwent pharmacokinetic and safety studies after single and multiple dose administration of nifedipine GITS (Gastro-Intestinal Therapeutic System) 60mg tablets." | 2.67 | Pharmacokinetic profile of nifedipine GITS in hypertensive patients with chronic renal impairment. ( Brendel, E; Griffel, L; Iaina, A; Kobelt, R; Schneider, R; Stolero, D, 1994) |
| "To determine whether verapamil, diltiazem, or nifedipine affect digitoxin kinetics, glycoside plasma concentrations and renal excretion were measured before and during steady-state dosing in 30 patients with cardiac insufficiency." | 2.66 | Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin. ( Kuhlmann, J, 1985) |
| " It compared the antihypertensive effect between increasing ARB dosage and the addition of controlled-release nifedipine." | 2.43 | [NICE-Combi study: effect of nifedipine in combination with an angiotensin II receptor blocker on BP control and renal protection]. ( Hasebe, N, 2006) |
| " The reported adverse effect profile for each of these drugs varies, but tends to hold true to drug class and are typified by the adverse reactions reported for nifedipine and amlodipine (dihydropyridines), diltiazem (benzothiazepines) and verapamil (phenylalkylamines)." | 2.39 | A comparative review of the adverse effects of calcium antagonists. ( Dougall, HT; McLay, J, 1996) |
| "Amlodipine, a dihydropyridine calcium antagonist, was synthesized in an attempt to develop a compound with a pharmacokinetic profile characteristic of this class, which would also have an increased oral bioavailability and extended clearance time." | 2.38 | The pharmacokinetic profile of amlodipine. ( Abernethy, DR, 1989) |
| " Nifedipine and irbesartan were taken after discharge, and the dosage was reduced gradually under supervision." | 1.48 | Hypertensive crisis with 2 target organ impairment induced by glycyrrhizin: A case report. ( Fan, X; Li, J; Wang, Q, 2018) |
| "Treatment with nifedipine (10, 20 mg/kg) significantly improved the renal dysfunction, tissue and urine total nitric oxide levels, and renal oxidative stress and prevented the alterations in renal morphology." | 1.33 | Nifedipine attenuates changes in nitric oxide levels, renal oxidative stress, and nephrotoxicity induced by cyclosporine. ( Chander, V; Chopra, K, 2005) |
| "Nifedipine and verapamil have been shown previously to protect against renal function alterations induced by shock wave lithotripsy (SWL) in humans and rats; however, the mechanism is unclear." | 1.30 | Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells. ( Chen, WC; Jan, CR; Tseng, CJ; Wu, SN, 1998) |
| " For acute control of blood pressure sublingual nifedipine was used in dosage of 0." | 1.29 | Malignant hypertension in children in India. ( Arora, P; Baijal, SS; Gulati, S; Kher, V; Kumar, P; Kumar, S; Rai, PK, 1996) |
| "Nilvadipine appears to be an effective hypotensive agent at single daily doses of 8 mg." | 1.28 | Nilvadipine in hypertension with renal dysfunction. ( Albert, FW; Berger, HH, 1992) |
| " If such an effect occurs in vivo, the ATP deficit will affect calcium extrusion pumps, so triggering vasoconstriction which is the major side effect of Cyclosporine A." | 1.28 | The restoration of ATP synthesis may explain the protective effect of calcium antagonists against cyclosporine A nephrotoxicity. ( Berland, Y; Chauvet-Monges, AM; Crevat, A; Dussol, B; Elsen, R; Salducci, MD, 1992) |
| "Treatment with nifedipine attenuated cyclosporine A-induced renal dysfunction and reduced urinary endothelin excretion." | 1.28 | Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number. ( Brooks, DP; Caltabiano, M; Contino, LC; Nambi, P; Ohlstein, EH; Pullen, M; Storer, B, 1991) |
| " A direct toxic effect of CsA on renal tubule epithelia was demonstrated using nigrosine uptake and LDH release as indicators of cell death." | 1.28 | Mechanisms of cyclosporine A toxicity in defined cultures of renal tubule epithelia: a role for cysteine proteases. ( Hartz, PA; Wilson, PD, 1991) |
| "Amlodipine was administered as 14 single 5-mg oral daily doses to 27 male subjects with renal function ranging from normal to haemodialysis-dependent." | 1.28 | Pharmacokinetics of amlodipine in renal impairment. ( Carmody, M; Donohue, J; Doyle, GD; Greb, H; Laher, M; Volz, M, 1989) |
| " Also on long-term administration of NIF in hypertensive patients, renal function improved." | 1.28 | [The effects of nifedipine on blood pressure and renal function]. ( Igarashi, N, 1989) |
| " The elimination half-life was of the order of 50 h, similar to previously observed values, and did not vary with differences in renal function." | 1.27 | Pharmacokinetics of amlodipine in renal impairment. ( Carmody, M; Donohoe, JF; Doyle, GD; Greb, H; Kelly, JG; Laher, MS; Volz, M, 1988) |
| " No significant differences were observed between Groups A, B and C (on an interdialysis day) in AUC (0-7h), tmax, Cmax and plasma protein binding." | 1.27 | Pharmacokinetics of nisoldipine in renal dysfunction. ( Ahr, G; Boelaert, J; Bogaert, MG; Dammekens, H; Daneels, R; De Vriese, G; Schurgers, M; Valcke, Y, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (36.67) | 18.7374 |
| 1990's | 18 (30.00) | 18.2507 |
| 2000's | 11 (18.33) | 29.6817 |
| 2010's | 9 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 2 |
| Fan, X | 1 |
| Wang, Q | 1 |
| Hammoud, SH | 1 |
| Alkhansa, S | 1 |
| Mahjoub, N | 1 |
| Omar, AG | 1 |
| El-Mas, MM | 1 |
| Eid, AA | 1 |
| Eraslan, E | 1 |
| Tanyeli, A | 1 |
| Polat, E | 2 |
| Akindele, AJ | 1 |
| Adeneye, AA | 1 |
| Olatoye, F | 1 |
| Benebo, AS | 1 |
| Alp Yildirim, FI | 1 |
| Eker Kizilay, D | 1 |
| Ergin, B | 1 |
| Balci Ekmekçi, Ö | 1 |
| Topal, G | 1 |
| Kucur, M | 1 |
| Demirci Tansel, C | 1 |
| Uydeş Doğan, BS | 1 |
| Liu, XD | 1 |
| Fu, J | 1 |
| Feng, MZ | 1 |
| Zhang, ZH | 1 |
| Dewan, P | 1 |
| Agarwal, N | 1 |
| Yamada, H | 1 |
| Suga, N | 1 |
| Maeda, K | 1 |
| Kimura, Y | 1 |
| Miura, N | 1 |
| Futenma, A | 1 |
| Imai, H | 1 |
| Veeramani, C | 1 |
| Aristatle, B | 1 |
| Pushpavalli, G | 1 |
| Pugalendi, KV | 1 |
| Ishii, T | 1 |
| Kawamura, T | 1 |
| Tsuboi, N | 1 |
| Hosoya, T | 1 |
| Maschio, G | 1 |
| Marcantoni, C | 1 |
| Bernich, P | 1 |
| de Araujo, M | 1 |
| Seguro, AC | 1 |
| Miller, DC | 1 |
| Wolf, JS | 1 |
| Chander, V | 1 |
| Chopra, K | 1 |
| Xie, HH | 1 |
| Shen, FM | 1 |
| Zhang, XF | 1 |
| Jiang, YY | 1 |
| Su, DF | 1 |
| Fomin, VV | 1 |
| Safonov, VV | 1 |
| Kozlovskaia, NL | 1 |
| Moiseev, SV | 1 |
| Osipenko, VI | 1 |
| Tironishvili, OI | 1 |
| Liu, LL | 1 |
| Li, QX | 1 |
| Xia, L | 1 |
| Shao, L | 1 |
| Hasebe, N | 1 |
| Diamond, JR | 1 |
| Cheung, JY | 1 |
| Fang, LS | 1 |
| Schneider, R | 1 |
| Stolero, D | 1 |
| Griffel, L | 1 |
| Kobelt, R | 1 |
| Brendel, E | 1 |
| Iaina, A | 1 |
| Mitamura, T | 1 |
| Yamada, A | 1 |
| Ishida, H | 1 |
| Fujihira, S | 1 |
| Ohara, K | 1 |
| Noguchi, H | 1 |
| Mine, Y | 1 |
| Zawadzki, J | 1 |
| Grenda, R | 1 |
| Januszewicz, P | 1 |
| Li, B | 1 |
| Zhou, W | 1 |
| Li, P | 1 |
| Zucchelli, P | 1 |
| Zuccalà, A | 1 |
| Ghoniem, GM | 1 |
| Dilworth, JP | 1 |
| Roberts, JA | 1 |
| Kumar, P | 1 |
| Arora, P | 1 |
| Kher, V | 1 |
| Rai, PK | 1 |
| Gulati, S | 1 |
| Baijal, SS | 1 |
| Kumar, S | 1 |
| Balakrishnan, VS | 1 |
| von Ruhland, CJ | 1 |
| Griffiths, DF | 1 |
| Coles, GA | 1 |
| Williams, JD | 1 |
| Dougall, HT | 1 |
| McLay, J | 1 |
| Jan, CR | 1 |
| Chen, WC | 1 |
| Wu, SN | 1 |
| Tseng, CJ | 1 |
| Suzuki, H | 1 |
| Nakamoto, H | 1 |
| Nemoto, H | 1 |
| Sugahara, S | 1 |
| Okada, H | 1 |
| Marin, R | 1 |
| Ruilope, LM | 1 |
| Aljama, P | 1 |
| Aranda, P | 1 |
| Segura, J | 1 |
| Diez, J | 1 |
| Berger, HH | 1 |
| Albert, FW | 1 |
| Salducci, MD | 1 |
| Chauvet-Monges, AM | 1 |
| Berland, Y | 1 |
| Dussol, B | 1 |
| Elsen, R | 1 |
| Crevat, A | 1 |
| Brooks, DP | 1 |
| Ohlstein, EH | 1 |
| Contino, LC | 1 |
| Storer, B | 1 |
| Pullen, M | 1 |
| Caltabiano, M | 1 |
| Nambi, P | 1 |
| McNally, PG | 2 |
| Baker, F | 2 |
| Mistry, N | 3 |
| Walls, J | 3 |
| Feehally, J | 3 |
| Wilson, PD | 1 |
| Hartz, PA | 1 |
| Rodicio Díaz, JL | 1 |
| Lheureux, P | 1 |
| Askenasi, R | 1 |
| Gangi, D | 1 |
| Laher, MS | 1 |
| Kelly, JG | 1 |
| Doyle, GD | 2 |
| Carmody, M | 2 |
| Donohoe, JF | 1 |
| Greb, H | 2 |
| Volz, M | 2 |
| Donohue, J | 1 |
| Laher, M | 1 |
| Abernethy, DR | 1 |
| Kiberd, BA | 1 |
| Soupart, A | 1 |
| Decaux, G | 1 |
| Igarashi, N | 1 |
| Shub, C | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| Loirat, C | 1 |
| Horsburgh, T | 1 |
| Taylor, J | 1 |
| Veitch, PS | 1 |
| Bell, PR | 1 |
| Kwan, JT | 1 |
| Foxall, PJ | 1 |
| Townend, JN | 1 |
| Bending, MR | 1 |
| Eisinger, AJ | 1 |
| Lee, SM | 1 |
| Michael, UF | 1 |
| Aronoff, GR | 1 |
| Sloan, RS | 1 |
| Boelaert, J | 1 |
| Valcke, Y | 1 |
| Dammekens, H | 1 |
| De Vriese, G | 1 |
| Ahr, G | 1 |
| Schurgers, M | 1 |
| Daneels, R | 1 |
| Bogaert, MG | 1 |
| Krog, M | 1 |
| Ejerblad, S | 1 |
| Johansson, H | 1 |
| Wilander, E | 1 |
| Bortolotti, M | 1 |
| Trisolino, G | 1 |
| Barbara, L | 1 |
| Lloret, J | 1 |
| Vila, A | 1 |
| Puig, X | 1 |
| Monmany, J | 1 |
| Muñoz, J | 1 |
| More, J | 1 |
| Kuhlmann, J | 1 |
| Kleinbloesem, CH | 1 |
| van Brummelen, P | 1 |
| van Harten, J | 1 |
| Danhof, M | 1 |
| Breimer, DD | 1 |
| Bursztyn, M | 1 |
| Grossman, E | 1 |
| Rosenthal, T | 1 |
| Moreira, J | 1 |
| Barata, JD | 1 |
| Olias, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Allopurinol on Malondialdehyde, Nitric Oxide, Kidney Injury Molecule-1 Urine Levels, Resistive Index and Renal Elastography in Kidney Stone Patients After Extra Corporeal Shockwave Lithotripsy[NCT05414669] | Phase 4 | 35 participants (Actual) | Interventional | 2020-08-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for nifedipine and Kidney Diseases
| Article | Year |
|---|---|
Lessons from large interventional trials on antihypertensive therapy in chronic renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Chronic Disease; Clini | 2002 |
[NICE-Combi study: effect of nifedipine in combination with an angiotensin II receptor blocker on BP control and renal protection].
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Doubl | 2006 |
Pharmacological treatment of renal parenchymal hypertension.
Topics: Antihypertensive Agents; Captopril; Humans; Hypertension, Renal; Incidence; Kidney Diseases; Models, | 1994 |
A comparative review of the adverse effects of calcium antagonists.
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular System; Endocrine System Diseases; Ga | 1996 |
The pharmacokinetic profile of amlodipine.
Topics: Administration, Oral; Aging; Amlodipine; Angina Pectoris; Animals; Biological Availability; Calcium | 1989 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
[Arterial hypertension in the newborn infant. Etiologies. Treatment].
Topics: Acebutolol; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Endoc | 1988 |
7 trials available for nifedipine and Kidney Diseases
| Article | Year |
|---|---|
[Effect of Jingui Shenqi pill combined with nifedipine for the treatment of elderly hypertensive patients with spleen-kidney Yang deficiency syndrome].
Topics: Aged; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Hypertension; Kidney Disease | 2015 |
Pharmacokinetic profile of nifedipine GITS in hypertensive patients with chronic renal impairment.
Topics: Administration, Oral; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Kidney Diseases; Mal | 1994 |
Protective effects of nifedipine and allopurinol on high energy shock wave induced acute changes of renal function.
Topics: Adolescent; Adult; Allopurinol; Female; Humans; Kidney Calculi; Kidney Diseases; Kidney Function Tes | 1995 |
A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Del | 2001 |
Nifedipine in the treatment of renal colic.
Topics: Adult; Blood Pressure; Colic; Female; Heart Rate; Humans; Kidney Diseases; Male; Nifedipine; Pain | 1986 |
Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin.
Topics: Aged; Benzazepines; Clinical Trials as Topic; Digitoxin; Diltiazem; Drug Interactions; Drug Therapy, | 1985 |
Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
Topics: Administration, Oral; Adult; Biological Availability; Blood Pressure; Chromatography, High Pressure | 1985 |
46 other studies available for nifedipine and Kidney Diseases
| Article | Year |
|---|---|
Hypertensive crisis with 2 target organ impairment induced by glycyrrhizin: A case report.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cholangitis; | 2018 |
Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.
Topics: Animals; Biomarkers; Blood Urea Nitrogen; Calcium Channel Blockers; Collagen Type IV; Creatinine; Cy | 2018 |
8-Br-cADPR, a TRPM2 ion channel antagonist, inhibits renal ischemia-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Blood Urea Nitrogen; Calcium Channel Blockers; Catalas | 2019 |
Protective effect of selected calcium channel blockers and prednisolone, a phospholipase-A2 inhibitor, against gentamicin and carbon tetrachloride-induced nephrotoxicity.
Topics: Animals; Antioxidants; Biomarkers; Calcium Channel Blockers; Carbon Tetrachloride; Cytoprotection; D | 2014 |
Barnidipine ameliorates the vascular and renal injury in L-NAME-induced hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cytoprotection; Disease | 2015 |
Klebsiella septicemia presenting as renal subcapsular abscess and hypertension in a neonate.
Topics: Female; Humans; Hypertension; Infant, Newborn; Kidney Diseases; Klebsiella Infections; Nifedipine; T | 2008 |
Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Creatinine; Dih | 2010 |
Antihypertensive efficacy of Melothria maderaspatana leaf extract on sham-operated and uninephrectomized DOCA-salt hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Cucurbitac | 2010 |
[CCB uptitration is superior to ARB uptitration in CKD patients who do not reach target blood pressure with ARB/CCB combined therapy].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Chro | 2010 |
Vasodilator agents protect against indinavir nephrotoxicity.
Topics: Animals; Arginine; HIV Protease Inhibitors; Indinavir; Kidney Diseases; Kidney Function Tests; Magne | 2003 |
Acute renal colic.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blo | 2004 |
Nifedipine attenuates changes in nitric oxide levels, renal oxidative stress, and nephrotoxicity induced by cyclosporine.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Cyclosporine; Disease Models, Animal; Immunohistochem | 2005 |
Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Aorta; Atenolol; Baroreflex; Biphenyl Compounds; Blood Pressure; C | 2006 |
[Ischemic disease of the kidneys in a patient with morbid obesity: characteristics of the course and diagnostic policy].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Diagnosis, Differential; Health Policy; Human | 2006 |
Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in rats.
Topics: Amlodipine; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blood Urea Nitrogen; Calci | 2007 |
Nifedipine-induced renal dysfunction. Alterations in renal hemodynamics.
Topics: Aged; Humans; Kidney Diseases; Male; Middle Aged; Nifedipine; Norepinephrine; Prostaglandins; Vasoco | 1984 |
Tacrolimus (FK506)-induced nephrotoxicity in spontaneous hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterioles; Blood Urea Nitrogen; Creatinine; Hypertension; Ki | 1994 |
Effect of nifedipine on tubular handling of uric acid in transplanted kidney on cyclosporine A treatment.
Topics: Adolescent; Adult; Child; Creatinine; Cyclosporine; Delayed-Action Preparations; Drug Therapy, Combi | 1995 |
Effect of nifedipine on kidney and ureteral function after experimental acute unilateral ureteral obstruction.
Topics: Animals; Colic; Glomerular Filtration Rate; Kidney; Kidney Diseases; Male; Muscle Contraction; Muscl | 1993 |
Malignant hypertension in children in India.
Topics: Adolescent; Angioplasty; Antihypertensive Agents; Child; Child, Preschool; Female; Humans; Hypertens | 1996 |
Effects of a selective adenosine A1 receptor antagonist on the development of cyclosporin nephrotoxicity.
Topics: Animals; Blood Pressure; Cyclosporine; Drug Interactions; Glomerular Filtration Rate; Immunosuppress | 1996 |
Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells.
Topics: Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Bradykinin; Calcium; Calcium Channel B | 1998 |
Control of blood pressure and prevention of end-organ damage in patients with accelerated hypertension by combination with arotinolol and extended release nifedipine.
Topics: Adrenergic beta-Antagonists; Adult; Biopsy; Blood Pressure; Calcium Channel Blockers; Creatinine; De | 2000 |
Nilvadipine in hypertension with renal dysfunction.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Creatinine; Female; Heart Rate; H | 1992 |
The restoration of ATP synthesis may explain the protective effect of calcium antagonists against cyclosporine A nephrotoxicity.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channels; Cyclosporine; Kidney; Kidney Diseases; M | 1992 |
Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Cyclosporins; Endothelins; Glomerular Filtration Rate; In | 1991 |
Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat.
Topics: Animals; Cyclosporins; Denervation; Female; Glomerular Filtration Rate; Kidney; Kidney Diseases; Nep | 1991 |
Mechanisms of cyclosporine A toxicity in defined cultures of renal tubule epithelia: a role for cysteine proteases.
Topics: Animals; Calcium; Cell Death; Cells, Cultured; Cyclosporine; Cysteine Endopeptidases; Cysteine Prote | 1991 |
Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity.
Topics: Animals; Cyclosporins; Disease Models, Animal; Female; Glomerular Filtration Rate; Hemodynamics; Kid | 1990 |
[Renal effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cyclosporins; Glomerular Filtration Rate; Humans; Kidney Diseases; Natriur | 1990 |
Unreliable effect of nifedipine in relieving renal colic.
Topics: Colic; Humans; Kidney Diseases; Nifedipine | 1990 |
Pharmacokinetics of amlodipine in renal impairment.
Topics: Adult; Aged; Amlodipine; Calcium Channel Blockers; Female; Half-Life; Humans; Kidney Diseases; Male; | 1988 |
Pharmacokinetics of amlodipine in renal impairment.
Topics: Adult; Aged; Amlodipine; Calcium Channel Blockers; Female; Half-Life; Humans; Kidney Diseases; Male; | 1989 |
Cyclosporine-induced renal dysfunction in human renal allograft recipients.
Topics: Cyclosporins; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Transplant | 1989 |
Nifedipine and amphotericin B nephrotoxicity in the rat.
Topics: Amphotericin B; Animals; Glomerular Filtration Rate; Hemodynamics; Kidney Diseases; Nifedipine; Rats | 1989 |
[The effects of nifedipine on blood pressure and renal function].
Topics: Administration, Oral; Adult; Animals; Blood Pressure; Humans; Hypertension; Kidney; Kidney Diseases; | 1989 |
Does nifedipine ameliorate cyclosporin A nephrotoxicity?
Topics: Adult; Cyclosporins; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Transplantation; Middle A | 1987 |
Does nifedipine ameliorate cyclosporin A nephrotoxicity?
Topics: Cyclosporins; Humans; Kidney Diseases; Kidney Transplantation; Middle Aged; Nifedipine | 1987 |
The protective effect of nitrendipine on gentamicin acute renal failure in rats.
Topics: Acute Kidney Injury; Animals; Female; Gentamicins; Hemodynamics; Kidney; Kidney Diseases; Kidney Fun | 1985 |
Nitrendipine kinetics in normal and impaired renal function.
Topics: Adult; Aged; Antihypertensive Agents; Biotransformation; Creatinine; Humans; Intestinal Absorption; | 1985 |
Calcium antagonist prevents nephrotoxicity.
Topics: Animals; Cyclosporins; Humans; Kidney; Kidney Diseases; Nifedipine; Rats | 1988 |
Pharmacokinetics of nisoldipine in renal dysfunction.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Female; Heart Rate; Humans; Kidney Diseases; | 1988 |
Tissue calcification and alkaline phosphatase activity in uraemic rats.
Topics: Alkaline Phosphatase; Animals; Aortic Diseases; Calcinosis; Calcitriol; Cardiomyopathies; Creatinine | 1988 |
Nifedipine in biliary and renal colic.
Topics: Biliary Tract Diseases; Colic; Humans; Kidney Diseases; Nifedipine | 1987 |
Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases.
Topics: Adult; Aged; Angina Pectoris; Asthma; Cerebrovascular Disorders; Diabetes Complications; Edema; Fema | 1985 |
Antihypertensive action of calcium blockade in hypertensive patients with chronic renal disease.
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Drug Therapy, Combination; Female; Humans; Hypertensio | 1985 |